Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Delaware for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Delaware only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Delaware (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Martha Hosford Skapof (NPI 1457301657)

Field	Value
Entity Type	Individual
Organization	Martha Hosford Skapof
Address	4701 Ogletown Stanton Rd
City	Newark
State	DE
ZIP	19713
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	May 11, 2006

Payer Source	Total Paid
Medicare	$748.2K
Medicaid	$0

Key Findings

Medicare revenue is the sole payer footprint for this provider: Total Medicare revenue is $748.2K and there is no Medicaid billing on file, making the provider effectively single‑payer from a public program perspective. The lack of Medicaid activity suggests contracting and utilization analyses should focus on Medicare fee schedules, prior authorization practices, and Medicare patient access rather than dual‑payer mix dynamics.

Revenue is highly concentrated in a small set of drugs and services: the precomputed top‑3 Medicare codes account for 83.4% of this provider's total Medicare revenue, and J9271 alone represents $533.2K or 71.7% of Medicare revenue. This degree of concentration indicates material exposure to utilization and reimbursement trends specific to a very small number of high‑cost oncology products.

Clinical/service‑line profile is consistent with outpatient oncology infusion: the largest revenue driver is J9271 (pembrolizumab) and the code mix also includes chemotherapy administration codes (96413, 96417, 96367) plus bone‑targeted therapy J0897 (denosumab). Together these codes point to an infusion‑based hematology/oncology practice that combines immunotherapy and supportive agents with routine office E/M visits.

Competitive standing for the primary drug is modest at the national level: J9271 (pembrolizumab) generates the majority of revenue but the provider ranks #910 of 1841 nationally (50th percentile) and is described as having typical, unremarkable volume for this code. Likewise, J0897 (denosumab) ranks #4543 of 10057 (54th percentile) and is also characterized as typical, indicating the provider is not an outlier or dominant national player for these agents.

Outpatient evaluation and management activity is sizable but characterized as routine: 99213 accounts for 500 claims, $33K revenue (4.4% of Medicare revenue) and ranks #27103 of 457151 (94th percentile) yet is labeled typical, unremarkable volume for this code. This suggests a meaningful stream of established‑patient office visits supporting infusion care, but not an anomalous pattern versus peers.

Several HCPCS entries show substantial claim counts with $0 average paid and $0 reported revenue (notably J1453, J2405, J1100), which is an operational detail worth investigating. These zero‑paid lines may reflect bundling, non‑covered items, or payment reporting conventions within Medicare claims data and should be reviewed before drawing conclusions about utilization.

Chemotherapy administration and add‑on infusion codes contribute measurable but secondary revenue: 96413 ($23K, 3.1% of Medicare revenue), 96417 ($6.3K, 0.8%), and 96367 ($6.3K, 0.8%) appear in the top codes and rank in mid‑range percentiles, supporting the view that infusion services are an active but not diversified revenue base. The presence of both initial and add‑on infusion codes is consistent with multi‑agent infusion sessions typical of oncology practices.

Provider tenure is long enough to assess stable patterns: the NPI was enumerated on 2006-05-11 (~20 years ago), indicating an established billing history. For payers and partners, this tenure combined with the concentrated oncology drug revenue profile signals a mature practice whose Medicare exposure is centered on a few high‑cost therapeutic agents.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

23 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	12,400	$40	$533.2K
J0897	Injection, denosumab, 1 mg	3,000	$20	$54K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	500	$70	$33K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	300	$100	$28.9K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	210	$110	$23K
J1439	Injection, ferric carboxymaltose, 1 mg	20,250	$1	$20.3K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	70	$140	$10.1K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	40	$170	$7.5K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	270	$20	$6.3K
96417	In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy…	120	$50	$6.3K

Showing 1–10 of 23

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Delaware Distribution

Martha Hosford Skapof — 0 of 20 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Delaware

Full comparison — all codes billed, vs. state median

23 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	7	10	17,600	$40	$992.4K
J0897	30	60	3,360	$20	$132.9K
96413	15	30	280	$100	$36.6K
99214	568	1,830	150	$80	$25.5K
J1439	2	10	20,250	$1	$16.3K
99232	523	730	120	$60	$14.2K
99213	210	1,810	120	$60	$13.6K
99215	181	570	40	$120	$11K
99223	477	500	50	$130	$10.4K
96417	6	10	130	$50	$6.8K

Showing 1–10 of 23

Related Providers

Other providers that share a Tax Identification Number (TIN) with Martha Hosford Skapof, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Christiana Care Health Services, Inc.	DE	General Acute Care Hospital	$0	$99.4M
Christiana Care Health Services Inc	DE	Hospitalist Physician	$0	$13.6M
Mercy Health System Corporation	WI	Multi-Specialty Clinic/Center	$0	$13.2M
Christiana Care Health Services Inc	DE	Obstetrics & Gynecology Physician	$0	$9.9M
Christiana Care Health Services Inc	DE	Neonatal-Perinatal Medicine Physician	$0	$8.9M
Medical Oncology Hematology Consultants PA	DE	Hematology & Oncology Physician	$0	$7.7M
Jamal Misleh	DE	Hematology & Oncology Physician	$6.8M	$0
Christiana Care Health Services Inc	DE	Family Medicine Physician	$0	$5.6M
Christiana Care Health Services Inc	DE	Neurology Physician	$0	$5.1M
Christiana Care Health Services, Inc	DE	Family Medicine Physician	$0	$5.1M

Nearby Providers

Other providers in the same ZIP code as Martha Hosford Skapof, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Associated Retinal Consultants LLC	DE	Ophthalmology Physician	$0	$25.2M
Columbus Medical Services, LLC	DE	Case Management Agency	$0	$18.7M
Caritas Home Health Services, Inc	DE	Home Health Agency	$0	$11.2M
Delaware Center For Maternal Fetal Medicine Of Christiana Care	DE	Maternal & Fetal Medicine Physician	$0	$9.8M
Christiana Care Quality Partners	DE	Urgent Care Clinic/Center	$0	$7M
Mid-atlantic Behavioral Health, LLC	DE	Intellectual & Developmental Disabilities Psychologist	$0	$6.5M
First State Orthopaedics, PA	DE	Orthopaedic Surgery Physician	$0	$6M
Autism Delaware	DE	Intellectual & Developmental Disabilities Psychologist	$0	$5.8M
Nephrology Associates PA	DE	Nephrology Physician	$0	$5.8M
Ent And Allergy Of Delaware LLC	DE	Specialist	$0	$5.4M

Martha Hosford Skapof — Billing Profile & Reimbursement Data

Sign up for Martha Hosford Skapof — Billing Profile & Reimbursement Data policy alerts

Martha Hosford Skapof — Billing Profile & Reimbursement Data

Sign up for Martha Hosford Skapof — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References